- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01404039
Investigating Motor Cortex Processing for Pain Modulation
Study Overview
Status
Conditions
Detailed Description
There are 5 experiments:
Exp1: motor learning (3 groups, crossover) - motor leaning with and without visual feedback and a control group.
Exp2: sensory learning (4 groups, parallel) - sensory learning with and without feedback, an simple activation task and a control group.
Exp3: observational task (2 groups, parallel) - an motor observational task and a control group.
Exp4: mental imagery (2 groups, parallel) - a motor mental imagery and a control group.
Exp5: tDCS over the motor cortex (2 groups, crossover) - active and sham tDCS. Note that this study has never been completed.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Spaulding Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Provide informed consent to participate in the study
- 18 to 64 years old
- No presence of rheumatologic disease as self reported
- No clinically significant or unstable medical or psychiatric disorder as self reported
- No history of alcohol or substance abuse within the last 6 months as self reported
- No neuropsychiatric co-morbidity as self reported
No Contraindications to single pulse TMS (TMS will be used to measure cortical excitability)
- history of seizures
- unexplained loss of consciousness
- metal in the head
- frequent or severe headaches or neck pain
- implanted brain medical devices
No Contraindications to tDCS
- metal in the head
- implanted brain medical devices
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motor Learning (ML) sighted
In this arm, subject will perform motor Learning with visual feedback - ML sighted. There will be an anticipated total of 15 subjects in this experimental arm. This arm will be conducted as a cross-over design. The subjects will undergo the three interventions listed (motor learning with visual feedback, motor learning without visual feedback, and control group) in a counterbalanced randomized order. There will be at least 24 hours between each experimental session. |
Subject will have to draw a set of shapes and words during 20 minutes.
|
|
Experimental: Motor Learning (ML) blind
In this arm, subject will perform motor Learning without visual feedback - ML blind. There will be an anticipated total of 15 subjects in this experimental arm. This arm will be conducted as a cross-over design. The subjects will undergo the three interventions listed (motor learning with visual feedback, motor learning without visual feedback, and control group) in a counterbalanced randomized order. There will be at least 24 hours between each experimental session. |
Subject will have to draw a set of shapes and words during 20 minutes.
|
|
Placebo Comparator: Motor Learning (ML) control group
In this arm, subject will perform simple hand movements - control group.
There will be an anticipated total of 15 subjects in this experimental arm.
This arm will be conducted as a cross-over design.
The subjects will undergo the three interventions listed (motor learning with visual feedback, motor learning without visual feedback, and control group) in a counterbalanced randomized order.
There will be at least 24 hours between each experimental session.
|
Subject will have to draw a set of shapes and words during 20 minutes.
|
|
Experimental: Somatosensory Learning (SL sighted)
In this arm, subject will perform sensory Learning with visual feedback - SL sighted. There will be an anticipated total of 10 subjects in this experimental arm. This experimental arm will be conducted in a parallel design with 4 groups (SL sighted, SL blind, Sactivation, SL control). |
Subjects will perform a learning task involving sensory activation of the hand.
The task will consist of learning letters of Braille.
|
|
Experimental: Somatosensory Learning (SL blind)
In this arm, subject will perform sensory Learning without visual feedback - SL blind. There will be an anticipated total of 10 subjects in this experimental arm. This experimental arm will be conducted in a parallel design with 4 groups (SL sighted, SL blind, Sactivation, SL control). |
Subjects will perform a learning task involving sensory activation of the hand.
The task will consist of learning letters of Braille.
|
|
Experimental: Somatosensory Activation (S activation)
In this arm, subject will receive simple sensory stimulation over their left index finger - Sactivation. There will be an anticipated total of 10 subjects in this experimental arm.This experimental arm will be conducted in a parallel design with 4 groups (SL sighted, SL blind, Sactivation, SL control). |
Subjects will perform a learning task involving sensory activation of the hand.
The task will consist of learning letters of Braille.
|
|
Placebo Comparator: Somatosensory Learning (SL) control group
In this arm,the subjects will not receive any somatosensory input (SL control group). There will be an anticipated total of 10 subjects in this experimental arm. This experimental arm will be conducted in a parallel design with 4 groups (SL sighted, SL blind, Sactivation, SL control). |
Subjects will perform a learning task involving sensory activation of the hand.
The task will consist of learning letters of Braille.
|
|
Experimental: Observational Task (OT) - real
In this arm, the subjects will perform an observational task - observation of hand movements.
This experimental arm will be conducted in a parallel design.
There will be 15 subjects per intervention.
|
Subjects will watch a 10 second video of a right-handed person performing movements of their left index finger.
Subjects will be instructed to watch the video without any other specific instruction.
|
|
Placebo Comparator: Observational Task (OT) - control group
In this arm, the subjects will perform a controlled observational task - observation of geometric shapes.
This experimental arm will be conducted in a parallel design.
There will be 15 subjects per intervention.
|
Subjects will watch a 10 second video of a right-handed person performing movements of their left index finger.
Subjects will be instructed to watch the video without any other specific instruction.
|
|
Experimental: Mental Imagery (MI) - real
In this arm, the subjects will perform mental imagery - mental imagery of finger movements.
This experimental arm will be conducted in a parallel design.
There will be 15 subjects per intervention.
|
Subjects will be asked to perform mental imagery of motor practice - finger movements of the left hand for 10 minutes.
|
|
Placebo Comparator: Mental Imagery (MI) - control group
In this arm, the subjects will perform a controlled task - simple mental calculation.
This experimental arm will be conducted in a parallel design.
There will be 15 subjects per intervention.
|
Subjects will be asked to perform mental imagery of motor practice - finger movements of the left hand for 10 minutes.
|
|
Experimental: transcranial direct current stimulation - tDCS real
tDCS will be applied over the motor cortex for 20minutes at an intensity of 2mA.
15 subjects will be enrolled.
The subjects will undergo two interventions, real and sham in a counterbalanced randomized order.
There will be at least 3 days between each experimental session.
|
Subjects will undergo active and sham tDCS stimulation in a randomized and counterbalanced order.
During both active and sham stimulation, we will use electrodes of 35cm^2, intensity of 2mA for a duration of 20 minutes.
The anode electrode will be placed over the right primary motor cortex (M1) and the cathode will be placed over the contralateral supraorbital area.
For active stimulation, the current will be on for the duration of 20 minutes.
For sham stimulation, the current will ramp up, and then down again for 30 seconds to simulate the sensation of active tDCS.
|
|
Placebo Comparator: transcranial direct current stimulation - tDCS sham
tDCS will be applied over the motor cortex for 20minutes at an intensity of 2mA. The stimulation will be stopped after 30seconds. 15 subjects will be enrolled. The subjects will undergo two interventions, real and sham in a counterbalanced randomized order. There will be at least 3 days between each experimental session. |
Subjects will undergo active and sham tDCS stimulation in a randomized and counterbalanced order.
During both active and sham stimulation, we will use electrodes of 35cm^2, intensity of 2mA for a duration of 20 minutes.
The anode electrode will be placed over the right primary motor cortex (M1) and the cathode will be placed over the contralateral supraorbital area.
For active stimulation, the current will be on for the duration of 20 minutes.
For sham stimulation, the current will ramp up, and then down again for 30 seconds to simulate the sensation of active tDCS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Motor Cortex Excitability MEP Amplitude
Time Frame: after each intervention
|
We aim to assess the effects of the intervention (ML, SL, OT and MI) on motor cortex excitability as measured by the change in motor evoked potential (using transcranial magnetic stimulation) before and after the given intervention.
|
after each intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2010-p-001256
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Motor Activity
-
University of MiamiRecruiting
-
University of MiamiCompleted
-
University of Massachusetts, AmherstActive, not recruiting
-
Pamukkale UniversityActive, not recruitingPhysical Activity | Motor DevelopmentTurkey (Türkiye)
-
Applied Science & Performance InstituteCompletedHealth Behavior | Nutrition, Healthy | Activity, MotorUnited States
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedMotor Activity | Motor NeuroplasticityUnited States
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPhysical Activity | Activity TrackersUnited States
Clinical Trials on Motor Learning
-
University of Southern CaliforniaRecruiting
-
University of Wisconsin, MadisonOffice of the Vice Chancellor for Research and Graduate Education; Wisconsin...Terminated
-
University of British ColumbiaUniversity of CalgaryUnknown
-
Omnya Samy Abdallah GhoneimCompleted
-
Arizona State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHealthy AdultsUnited States
-
Inonu UniversityRecruitingCerebral Palsy | Telerehabilitation | Motor LearningTurkey
-
Universite du Littoral Cote d'OpaleRecruitingMotor Learning | Corticospinal ExcitabilityFrance
-
Istanbul Medeniyet UniversityIstanbul University - Cerrahpasa (IUC)Completed
-
Hacettepe UniversityCompletedExercise Addiction | Proprioceptive Disorders | Syringomyelia | Chiari Malformation Type I | Coordination and Balance Disturbances | Basilar Invagination | Atlanto-Axial SubluxationTurkey
-
University of Erlangen-NürnbergGerman Foundation for Neurology; Department of Molecular Neurology, Faculty...Completed